What Does This Mean for Patients Currently Using Compounded GLP-1s
In fact, studies have shown that GLP-1 agonists can positively affect cardiovascular health, offering you an additional layer of protection while you shed those excess pounds
One of them is MEDVi GLP-1 receptor agonists such as semaglutide and tirzepatide, which has gained attention because of its ability to control the appetite and decrease weight under the supervision of medical professionals
From initial labs to weekly follow-ups, treatment plans are adjusted based on your biology, medication response, and side effect profile
Discordance between central (brain) and pancreatic action of exenatide in lean and obese subjects
The dual-agonist question One theoretical question that researchers have not fully addressed is whether tirzepatide's GIP activation creates any additional considerations during breastfeeding